BIOGEN TO PRESENT AT BERNSTEIN’S 35TH ANNUAL STRATEGIC DECISIONS CONFERENCE

On May 21, 2019 Biogen Inc. (Nasdaq: BIIB) reported that it will present at Bernstein’s 35th Annual Strategic Decisions Conference (Press release, Biogen, MAY 21, 2019, View Source [SID1234536525]). The webcast will be live on Thursday, May 30, at 10:00 a.m. ET. To access the live webcast, please visit Biogen’s Investors section at www.biogen.com/investors. An archived version of the webcast will be available following the presentation.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!